NEW YORK (GenomeWeb News) – Agilent Technologies today announced the offering of a series of senior notes.
The company also restated its earnings for fiscal 2011, ended Oct. 31, 2011, in order to reflect the recent $2.2 billion purchase of Dako.
Registering provides access to this and other free content.
Already have an account?Login Now.
The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.
Kaiser Health News reports that gene therapies could cost more than a million dollars.
Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.
In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.